NCT07563270 GAPcareAD: A Brief Emergency Department Intervention to Address Post-Fall Care Needs of Persons Living With Dementia and Care Partners
| NCT ID | NCT07563270 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Alzheimer's Disease and Related Dementia |
| Study Type | INTERVENTIONAL |
| Enrollment | 700 participants |
| Start Date | 2026-10-13 |
| Primary Completion | 2029-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 700 participants in total. It began in 2026-10-13 with a primary completion date of 2029-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Persons living with dementia (PLWD) are at significantly increased risk for falls, which are the leading cause of emergency department (ED) visits in this population and contribute to serious injuries, functional decline, and caregiver burden. GAPcareAD is an ED-initiated, caregiver-inclusive intervention designed to address fall risk at the point of care. This multi-site trial will compare GAPcareAD (intervention) to usual care for 350 PLWD and caregivers after a fall.
Eligibility Criteria
Inclusion Criteria: * Community-dwelling adult (living at home or assisted living) 65 years-old or older presenting to ED after a fall within the last seven days * Fall not due to syncope or external force (i.e., struck by car,assault, intoxication) * Fall not due to serious illness (i.e., stroke, acute myocardial infarction) * Patients have an identified caregiver * Patient must have known ADRD or score ≥2 on the AD8 Dementia Interview. * Anticipated to be discharged to home/assisted living/rehabilitation at the time of consent (i.e. not admitted) * The patient and/or caregiver have a reliable phone number where they can be reached throughout the intervention Exclusion Criteria: * Living in a nursing home * Patients are admitted to the hospital * Patients who have advanced cancer and/or are in hospice * Patients have presence of injuries that prevent mobilization (i.e. pelvic or lower extremity fractures)
Frequently Asked Questions
Who can join the NCT07563270 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Alzheimer's Disease and Related Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07563270 currently recruiting?
Yes, NCT07563270 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Colorado, Denver to inquire about joining.
Where is the NCT07563270 trial being conducted?
This trial is being conducted at Aurora, United States, St Louis, United States.
Who is sponsoring the NCT07563270 clinical trial?
NCT07563270 is sponsored by University of Colorado, Denver. The trial plans to enroll 700 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.